Europe Deep Brain Stimulation Systems Market – Industry Trends and Forecast to 2030

Europe Deep Brain Stimulation Systems Market, By Type (Subthalamic DBS, Globus pallidus DBS, Thalamic DBS, Pedunculopontine nucleus DBS), Product Type (Single-Channel Deep Brain Stimulator, Dual-Channel Deep Brain Stimulator), Applications (Parkinson's disease, Epilepsy, Essential Tremor, Dystonia, Tourette syndrome, Obsessive Compulsive Disorder and Other Applications), End User (Neurological Clinics, Ambulatory Surgical Centers, Hospital and Others) – Industry Trends and Forecast to 2030.

Europe Deep Brain Stimulation Systems Market Analysis and Size

According to the World Health Organization, neurological illnesses account for 6.3 percent of disease burden and are one of the leading causes of death, accounting for 13.2% of fatalities in affluent nations and 16.8% in low- and middle-income countries. Clinical urgency for long-term remedies such as deep brain stimulators is created by high mortality and illness burden. Furthermore, as the public becomes more aware of the tremendous burden of neurological disease, demand for deep brain stimulators as an alternative therapy has increased. During the forecast period, this is expected to fuel market expansion. The growing prevalence of neurological illnesses such as Parkinson's disease, essential tremors, dystonia, and epilepsy is a major market driver for deep brain stimulators.

Data Bridge Market Research analyses that the deep brain stimulation systems market value is USD 0.88 billion in 2022, is expected to reach USD 5.18 billion by 2030, at a CAGR of 24.8% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Europe Deep Brain Stimulation Systems Market Scope and Segmentation

Market Definition

Deep brain stimulation is a surgical procedure in which an electrical device is implanted in the brain. Electrical signals are sent from the gadget to the areas of the brain that govern movement. These devices are used to treat a variety of neurological diseases, including epilepsy, dystonia, Parkinson's disease, essential tremor, and obsessive compulsive disorder.

Europe Deep Brain Stimulation Systems Market Dynamics

Drivers

• Rise in ageing population

According to the United Nations Department of Economic and Social Affairs report titled 'World Population Ageing 2020 Highlights,' there will be 727 million people in the world aged 65 and up in 2020. It is expected to more than double to nearly 1.5 billion by 2050. The elderly population is expected to grow, and this population is more vulnerable to neurological disorders, which will drive the market in the near future. There are currently several deep brain stimulation systems that European and American regulatory agencies have approved. The Vercise Deep Brain Stimulation (DBS) System from Boston Scientific Corporation has been approved by the US Food and Drug Administration (FDA). This system is used to treat Parkinson's disease symptoms (PD). These are the factors which propel the market growth.

• Launch of new products

Innovative product launches are expected to drive the growth of the market during the forecast period. For intsance, in 2021, Medtronic launched the first-of-its-kind Adaptive deep brain stimulation (aDBS) trial to assess the safety and efficacy of adaptive deep brain stimulation in Parkinson's disease patients. Furthermore, rising technological advancement in the field of deep brain stimulation, which is propelling the market's overall growth.

• Occurrences of neurological disorders

The rise in neurological diseases such as epilepsy, Parkinson's disease, Alzheimer's disease, and chronic pain is also affecting the market. Furthermore, severe adverse effects and medication interactions caused by non-targeted drug absorption are expected to drive demand for DBS devices. These medications can significantly improve motor function, but they can also have side effects, especially as the disease progresses. Long-term use of the drug levodopa, for example, can result in hallucinations, dyskinesia, neurotoxic effects, and severe metabolic abnormalities. As a result of such side effects, clinicians are increasingly turning to specialised treatment options, such as deep brain stimulators. As a result, market growth will accelerate during the forecast period.

Opportunities

• Advancements in fundamental neuroscience

More advances in fundamental neuroscience, as well as other fields of research and technology, are expected to broaden the therapeutic application of DBS. DBS demonstrates an extremely clear link between basic science, clinical research, and therapeutic practise, making it both humanitarian and scientifically fascinating. There may be problems ahead, as with any new field of research, but DBS holds a lot of promise, and there's reason to believe that the next 50 years of progress will provide even more benefits than the previous 50.

Restraints/Challenges

• Side effects associated to deep brain stimulation systems

Concerns about side effects such as allergic reaction and skin tingling or prickling, on the other hand, are expected to stymie market growth. The availability of other treatment options, such as medication therapy and surgeries, is expected to pose a challenge to the deep brain stimulation systems market during the forecast period of 2023-2030.

• High cost

This cost issue is particularly problematic in developing countries, where few people can afford the hardware and treatment costs despite the high prevalence of movement disorders and other illnesses that can be treated with DBS. Although the lack of surgical facilities and experience may continue to be a barrier, further development of low-cost IPGs may help alleviate this issue.

This deep brain stimulation systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the deep brain stimulation systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Deep Brain Stimulation Systems Market

COVID-19 is expected to have a significant impact on market growth. According to an article titled 'Deep Brain Stimulation for Parkinson's Disease During the COVID-19 Pandemic: Patient Perspective,' published in April 2021, the three main reasons given by patients for seeking deep brain stimulation surgery during the COVID-19 virus outbreak were routine clinical referral, personal safety provided by hospital care, and poor control of severe Parkinson's disease symptoms. As a result, rising demand for deep brain stimulation procedures is expected to drive market growth during the pandemic period.

Recent Developments

• In 2020, Medtronic's Percept PC neurostimulator received the CE mark. This Deep Brain Stimulation (DBS) device employs BrainSense technology. Patients suffering from neurologic diseases such as Parkinson's disease can benefit from the system's ability to detect and record brain signals while undergoing treatment.
• In 2020, Abbott Laboratories' Infinity Deep Brain Stimulation (DBS) device approved by the US Food and Drug Administration (FDA). This system would be used to treat Parkinson's disease. By targeting a specific area of the brain known as the internal globus pallidus, the technology would be able to improve Parkinson's disease symptoms that are not controlled by medication.

Europe Deep Brain Stimulation Systems Market Scope

The deep brain stimulation systems market is segmented on the basis of product type, applications and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Subthalamic DBS
• Globus pallidus DBS
• Thalamic DBS
• Pedunculopontine nucleus DBS

Product Type

• Single-Channel Deep Brain Stimulator
• Dual-Channel Deep Brain Stimulator

Applications

• Parkinson's disease
• Epilepsy
• Essential Tremor
• Dystonia
• Obsessive Compulsive Disorder
• Other Applications

End-User

• Neurological Clinics
• Ambulatory Surgical Centers
• Hospital
• Others

Deep Brain Stimulation Systems Market Regional Analysis/Insights

The deep brain stimulation systems market is analyzed and market size insights and trends are provided by country, product type, type, application and end-user as referenced above.

The countries covered in the deep brain stimulation systems market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe.

Germany is growing with the highest market share because it is a developed country with a large number of deep brain stimulation system companies. Furthermore, technological advancements and specific applications related to deep brain stimulation systems have created new research opportunities.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The deep brain stimulation systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for deep brain stimulation systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the deep brain stimulation systems market. The data is available for historic period 2011-2021.

Competitive Landscape and Deep Brain Stimulation Systems Market Share Analysis

The deep brain stimulation systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to deep brain stimulation systems market.

Some of the major players operating in the deep brain stimulation systems market are:

• Boston Scientific Corporation (U.S.)
• Fisher Wallace (U.S.)
• SceneRay Corporation, Limited (China)
• Beijing PINS Medical Co., Ltd (China)
• ALEVA NEUROTHERAPEUTICS SA (Switzerland)
• Medtronic (Ireland)
• Abbott (U.S.)
• Deep Brain Innovations, LLC (U.S.)
• St. Jude Children's Research Hospital (U.S.)
• Stanford Health Care (U.S.)
• NeuroPace Inc. (U.S.)
• Renishaw plc. (U.S.)
• Functional Neuromodulation Ltd. (Canada)